Church & Dwight Co Inc

Church & Dwight’s decade‑long surge shows 119% growth and 8.5% CAGR, outpacing rivals with steady cash flow and a $24 B market cap—an attractive yet high‑valued investment for patient shareholders.

Church & Dwight Q3 beats estimates, lifts 2025 outlook, with stronger detergent sales, lower tariffs, and solid cash flow driving a fresh growth push.

Church & Dwight’s Q3 earnings outlook shows a strong rebound—positive EPS, steady dividends, and growth in contraceptives—positioning the $20 B stock for upside.

Church & Dwight Co Inc reported Q1 earnings that beat expectations, but organic sales declined, prompting a revised growth forecast due to ongoing tariff challenges.